Wire · regulatory
Reflections on the National Commission into the Regulation of AI in Healthcare recommendations
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 23 September 2026 · Fusion42 review
The UK National Commission into the Regulation of AI in Healthcare published 44 recommendations focused on a proportionate, lifecycle-based regulatory framework that emphasises post-market surveillance and enhanced enforcement including financial penalties. Key gaps identified include lack of integration with existing patient safety incident systems like Learn from Patient Safety Events (LFPSE) and clinical safety infrastructure.
This Wire brief sits within Fusion42's coverage of Digital Health, and 2 sources have reported it between 10 Sep 2026 and 23 Sep 2026.
◆ ◆ The Wire takeaway
You face new rules that hold AI product makers financially accountable and focus on real-world safety after launch. Prepare now to align your clinical AI tools with ongoing surveillance and incident reporting systems including LFPSE to avoid blind spots and regulatory risk.
◆ Coverage
2 sources · first reported 10 Sep 2026 · latest 23 Sep 2026
◆ Related on Wire
◆ Topics